Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in children and young adults with SMA
NCT00774423Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2006
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of riluzole in spinal muscular atrophy (SMA), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2006; status: completed.
02
Drugs
riluzole
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on NCT00774423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00774423.